120 related articles for article (PubMed ID: 16651719)
1. Effects of antifungal drugs on proliferation signals in Candida albicans.
Matsuki M; Kanatsu H; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
Biol Pharm Bull; 2006 May; 29(5):919-22. PubMed ID: 16651719
[TBL] [Abstract][Full Text] [Related]
2. Antifungal mechanism of hinokitiol against Candida albicans.
Komaki N; Watanabe T; Ogasawara A; Sato N; Mikami T; Matsumoto T
Biol Pharm Bull; 2008 Apr; 31(4):735-7. PubMed ID: 18379073
[TBL] [Abstract][Full Text] [Related]
3. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of Candida albicans transformation in response to changes of pH.
Konno N; Ishii M; Nagai A; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
Biol Pharm Bull; 2006 May; 29(5):923-6. PubMed ID: 16651720
[TBL] [Abstract][Full Text] [Related]
5. Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans.
Sun L; Liao K; Wang D
PLoS One; 2015; 10(2):e0117695. PubMed ID: 25710475
[TBL] [Abstract][Full Text] [Related]
6. Hyphal formation of Candida albicans is inhibited by salivary mucin.
Ogasawara A; Komaki N; Akai H; Hori K; Watanabe H; Watanabe T; Mikami T; Matsumoto T
Biol Pharm Bull; 2007 Feb; 30(2):284-6. PubMed ID: 17268066
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of yeast-to-hypha transition in Candida albicans by phorbasin H isolated from Phorbas sp.
Lee SH; Jeon JE; Ahn CH; Chung SC; Shin J; Oh KB
Appl Microbiol Biotechnol; 2013 Apr; 97(7):3141-8. PubMed ID: 23229567
[TBL] [Abstract][Full Text] [Related]
8. Effect of propranolol on hyphae formation signal in Candida albicans.
Ueno Y; Maruyama N; Kanno M; Watanabe T; Ogasawara A; Mikami T; Matsumoto T
Biol Pharm Bull; 2009 Jan; 32(1):129-31. PubMed ID: 19122294
[TBL] [Abstract][Full Text] [Related]
9. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade.
Sato T; Watanabe T; Mikami T; Matsumoto T
Biol Pharm Bull; 2004 May; 27(5):751-2. PubMed ID: 15133261
[TBL] [Abstract][Full Text] [Related]
10. The inhibitory activity of linalool against the filamentous growth and biofilm formation in Candida albicans.
Hsu CC; Lai WL; Chuang KC; Lee MH; Tsai YC
Med Mycol; 2013 Jul; 51(5):473-82. PubMed ID: 23210679
[TBL] [Abstract][Full Text] [Related]
11. Hyphal formation of Candida albicans is controlled by electron transfer system.
Watanabe T; Ogasawara A; Mikami T; Matsumoto T
Biochem Biophys Res Commun; 2006 Sep; 348(1):206-11. PubMed ID: 16876761
[TBL] [Abstract][Full Text] [Related]
12. The role of diclofenac sodium in the dimorphic transition in Candida albicans.
Ghalehnoo ZR; Rashki A; Najimi M; Dominguez A
Microb Pathog; 2010; 48(3-4):110-5. PubMed ID: 20026399
[TBL] [Abstract][Full Text] [Related]
13. Boric acid destabilizes the hyphal cytoskeleton and inhibits invasive growth of Candida albicans.
Pointer BR; Boyer MP; Schmidt M
Yeast; 2015 Apr; 32(4):389-98. PubMed ID: 25612315
[TBL] [Abstract][Full Text] [Related]
14. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
15. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes.
MacPherson S; Akache B; Weber S; De Deken X; Raymond M; Turcotte B
Antimicrob Agents Chemother; 2005 May; 49(5):1745-52. PubMed ID: 15855491
[TBL] [Abstract][Full Text] [Related]
16. The Dietary Food Components Capric Acid and Caprylic Acid Inhibit Virulence Factors in Candida albicans Through Multitargeting.
Jadhav A; Mortale S; Halbandge S; Jangid P; Patil R; Gade W; Kharat K; Karuppayil SM
J Med Food; 2017 Nov; 20(11):1083-1090. PubMed ID: 28922057
[TBL] [Abstract][Full Text] [Related]
17. Candida albicans PHO81 is required for the inhibition of hyphal development by farnesoic acid.
Chung SC; Kim TI; Ahn CH; Shin J; Oh KB
FEBS Lett; 2010 Nov; 584(22):4639-45. PubMed ID: 20965180
[TBL] [Abstract][Full Text] [Related]
18.
Kim H; Hwang JY; Chung B; Cho E; Bae S; Shin J; Oh KB
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30813382
[TBL] [Abstract][Full Text] [Related]
19. Antifungal activity of clotrimazole against Candida albicans depends on carbon sources, growth phase and morphology.
Kasper L; Miramón P; Jablonowski N; Wisgott S; Wilson D; Brunke S; Hube B
J Med Microbiol; 2015 Jul; 64(7):714-723. PubMed ID: 25976001
[TBL] [Abstract][Full Text] [Related]
20.
Çolak A; Ikeh MAC; Nobile CJ; Baykara MZ
mSphere; 2020 Nov; 5(6):. PubMed ID: 33148826
[No Abstract] [Full Text] [Related]
[Next] [New Search]